Clinical Trial Update: COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating COVID-19 CoronaVac in patients with autoimmune rheumatic diseases and HIV/AIDS; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Rheumatic Disease

Drugs mentioned

• CoronaVac (Inactivated SARS-CoV-2 vaccine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Rheumatic Disease, HIV Infections | Phase 4 | Status: COMPLETED